Hilton, T. L., Hulett, T. W., Dubay, C., van de Ven, R., Aung, S., Urba, W. J., . . . Fox, B. A. (2013). DPV-001 an autophagosome-enriched cancer vaccine in phase II clinical trials contains 25 putative cancer antigens, DAMPS, HSPS and agonists for TLR 2, 3, 4, 7 and 9. BioMed Central.
Styl cytowania ChicagoHilton, Traci L., Tyler W. Hulett, Chistopher Dubay, Rieneke van de Ven, Sandra Aung, Walter J. Urba, Hong Ming Hu, i Bernard A. Fox. DPV-001 an Autophagosome-enriched Cancer Vaccine in Phase II Clinical Trials Contains 25 Putative Cancer Antigens, DAMPS, HSPS and Agonists for TLR 2, 3, 4, 7 and 9. BioMed Central, 2013.
Styl cytowania MLAHilton, Traci L., et al. DPV-001 an Autophagosome-enriched Cancer Vaccine in Phase II Clinical Trials Contains 25 Putative Cancer Antigens, DAMPS, HSPS and Agonists for TLR 2, 3, 4, 7 and 9. BioMed Central, 2013.